Exchange Traded Concepts’s Collegium Pharmaceutical COLL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.9M	Buy	57,433 +36,966	+181%	+$1.57M	0.01%	627
2025 Q4	$948K	Sell	20,467 -600	-3%	-$25.1K	0.01%	831
2025 Q3	$737K	Sell	21,067 -44,065	-68%	-$1.53M	0.01%	930
2025 Q2	$1.93M	Buy	65,132 +2,706	+4%	+$77.2K	0.02%	493
2025 Q1	$1.86M	Sell	62,426 -12,669	-17%	-$387K	0.03%	392
2024 Q4	$2.15M	Buy	75,095 +3,402	+5%	+$113K	0.04%	357
2024 Q3	$2.77M	Buy	71,693 +5,469	+8%	+$195K	0.07%	252
2024 Q2	$2.13M	Buy	66,224 +3,695	+6%	+$128K	0.05%	279
2024 Q1	$2.43M	Buy	+62,529	New	+$2.19M	0.06%	265
2023 Q1	–	Sell	-77,435	Closed	-$1.8M	–	1165
2022 Q4	$1.8M	Buy	77,435 +2,364	+3%	+$47.7K	0.05%	196
2022 Q3	$1.2M	Sell	75,071 -1,402	-2%	-$24.7K	0.04%	228
2022 Q2	$1.35M	Buy	76,473 +2,278	+3%	+$38.3K	0.04%	235
2022 Q1	$1.51M	Buy	74,195 +50,785	+217%	+$960K	0.03%	256
2021 Q4	$437K	Buy	23,410 +423	+2%	+$8.25K	0.01%	712
2021 Q3	$454K	Buy	+22,987	New	+$497K	0.01%	658